Results 191 to 200 of about 2,879,932 (270)

Determinants of frequent use of open consultations: a study on patient demographics, chronic conditions, and utilization patterns in primary care. [PDF]

Porto Biomed J
Leitão CA, Santos SR, Aguiar AS, Sousa VL, Lanhas HA, Alves FM.   +5 more
europepmc   +1 more source

Length of stay and prior heart failure admission in frailty and heart failure: A systematic review and meta‐analysis

ESC Heart Failure, EarlyView.
Abstract Aims The aim of this study was to compare the differences in length of stay (LoS) and prior hospitalization due to heart failure (HHF) in patients with HF and frailty versus without frailty. Methods and results From inception until August 2024, PubMed, Scopus, Web of Science and Cochrane Library were searched.
Konstantinos Prokopidis, Amy Nortcliffe, Chukwuma Okoye, Massimo Venturelli, Gregory Y. H. Lip, Masoud Isanejad   +5 more
wiley   +1 more source

Network analysis of extraintestinal manifestations and associated autoimmune disorders in Crohn's disease and ulcerative colitis. [PDF]

NPJ Digit Med
Baumgart DC, Cheng CH, Du TX, Parkes MD, Sadowski DC, Wine E, Hoentjen F, Halloran BP, Montano-Loza A, Zepeda-Gomez S, Wong K, Peerani F, Goebel R, Ross Mitchell J.   +13 more
europepmc   +1 more source

Skeletal muscle and subcutaneous fat quantity as prognostic indicators in cardiac amyloidosis

European Journal of Heart Failure, EarlyView.
Aims Disease‐related changes in body composition are associated with worse outcomes in chronic heart failure. In cardiac amyloidosis (CA), the prognostic value of direct body composition measures is understudied. Methods and results We identified 160 consecutive patients with CA (transthyretin [ATTR] or light chain [AL]) diagnosed between 2001 and 2021
Joshua Longinow, Saeid Mirzai, Po‐Hao Chen, Mazen Hanna, W.H. Wilson Tang   +4 more
wiley   +1 more source

Diagnosing and Reporting of Occupational Diseases: An Assessment Study of Reports from an Italian Workplace Safety Prevention Program Service. [PDF]

Med Lav
Lecca LI, Pili S, Lai M, Murru A, Campo G, Pizzuti A, Mattioli S, Campagna M.   +7 more
europepmc   +1 more source

How to handle polypharmacy in heart failure. A clinical consensus statement of the Heart Failure Association of the ESC

European Journal of Heart Failure, EarlyView.
Linking guideline‐directed medical therapy (GDMT) implementation and appropriate polypharmacy management in heart failure (HF). Polypharmacy can represent a barrier to the proper implementation of life‐prolonging GDMT for HF. A reasonable balance between the optimization of GDMT and avoiding inappropriate polypharmacy is mandatory in the contemporary ...
Davide Stolfo, Massimo Iacoviello, Ovidiu Chioncel, Markus S. Anker, Antoni Bayes‐Genis, Frieder Braunschweig, Antonio Cannata, Seif El Hadidi, Gerasimos Filippatos, Pardeep Jhund, Alexandre Mebazaa, Brenda Moura, Massimo Piepoli, Robin Ray, Arsen D. Ristic, Petar Seferovic, Maggie Simpson, Hadi Skouri, Carlo Gabriele Tocchetti, Sophie Van Linthout, Cristiana Vitale, Maurizio Volterrani, Kalliopi Keramida, Sven Wassmann, Basil S. Lewis, Marco Metra, Giuseppe M.C. Rosano, Gianluigi Savarese   +27 more
wiley   +1 more source

Value of semi-quantitative scoring based on musculoskeletal ultrasound in diagnosis and disease assessment of gouty arthritis. [PDF]

Clin Exp Med
Zhang P, Li D, Li D.
europepmc   +1 more source

Fatigue and the Impact of Musculoskeletal Pain on Quality of Life in Pediatric Patients With Psoriasis. [PDF]

J Psoriasis Psoriatic Arthritis
Meneghetti TC, Carvalho VO, de Carvalho LM, Ferriani VPL.   +3 more
europepmc   +1 more source

Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)

Environmental and Molecular Mutagenesis, EarlyView.
Abstract Exposure levels without appreciable human health risk may be determined by dividing a point of departure on a dose–response curve (e.g., benchmark dose) by a composite adjustment factor (AF). An “effect severity” AF (ESAF) is employed in some regulatory contexts.
Barbara L. Parsons, Marc A. Beal, Kerry L. Dearfield, George R. Douglas, Min Gi, B. Bhaskar Gollapudi, Robert H. Heflich, Katsuyoshi Horibata, Michelle Kenyon, Alexandra S. Long, David P. Lovell, Anthony M. Lynch, Meagan B. Myers, Stefan Pfuhler, Alisa Vespa, Andreas Zeller, George E. Johnson, Paul A. White   +17 more
wiley   +1 more source

Assessing causality between mitochondrial-associated proteins with musculoskeletal diseases: A Mendelian randomization study. [PDF]

Medicine (Baltimore)
Li JC, Huang WS, Yang DH, He QF, Sun W.
europepmc   +1 more source